Scilex Holding (SCLX) Interest Coverage Ratio (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Interest Coverage Ratio of 2.15 for Q1 2026, up 69.11% year-over-year from 1.27 in Q1 2025, and up 98.23% quarter-over-quarter from 121.81 in Q4 2025.
Scilex Holding (SCLX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Scilex Holding's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 2.15 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 69.11% year-over-year to 2.15; the TTM figure through Mar 2026 stood at 23.42 (down 2.19% YoY), while the FY2025 annual figure was 30.2, down 4016.74% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.15, up from 121.81 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.23 in Q1 2023, with the low at 1385.39 in Q2 2022.
- The 5-year median for Interest Coverage Ratio is 6.96 (2025), against an average of 106.08.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio jumped 99.97% in 2023, then plunged 2038.18% in 2024.
- Scilex Holding's Interest Coverage Ratio stood at 19.58 in 2022, then tumbled by 85.8% to 36.39 in 2023, then slumped by 173.65% to 99.57 in 2024, then dropped by 22.33% to 121.81 in 2025, then jumped by 98.23% to 2.15 in 2026.
- Business Quant data shows SCLX's Interest Coverage Ratio at 2.15 in Q1 2026, 121.81 in Q4 2025, and 45.68 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.61 Bn | 630.85 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 470.09 Bn | 463.53 Bn | 12.70 Bn | - |
| 3 | Merck | 374.19 Bn | 367.05 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 302.72 Bn | 295.03 Bn | 11.24 Bn | 10.28 |
| 5 | Astrazeneca | 257.19 Bn | 252.29 Bn | 12.86 Bn | 7.27 |
| 6 | Amgen | 236.77 Bn | 222.78 Bn | 7.24 Bn | 5.22 |
| 7 | Gilead Sciences | 182.67 Bn | 179.49 Bn | 6.22 Bn | -42.08 |
| 8 | Pfizer | 159.54 Bn | 147.84 Bn | 10.94 Bn | - |
| 9 | Gsk | 105.97 Bn | 101.81 Bn | 8.24 Bn | -2.64 |
| 10 | Scilex Holding | 38.94 Mn | -73.85 Mn | 3.97 Mn | -4.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15 |
| Dec 31, 2025 | -121.81 |
| Sep 30, 2025 | -45.68 |
| Jun 30, 2025 | -5.02 |
| Mar 31, 2025 | -6.96 |
| Dec 31, 2024 | -99.57 |
| Sep 30, 2024 | -4.97 |
| Jun 30, 2024 | -2.35 |
| Mar 31, 2024 | -4.86 |
| Dec 31, 2023 | -36.39 |
| Sep 30, 2023 | -9.69 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | -19.58 |
| Sep 30, 2022 | -5.71 |
| Jun 30, 2022 | -1,385.39 |
| Mar 31, 2022 | -52.73 |
| Dec 31, 2021 | -3.01 |
| Mar 31, 2021 | -3.30 |
| Dec 31, 2020 | -0.13 |